Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its third-quarter 2024 earnings, highlighting a steady increase in revenue and strategic developments in product innovation and market expansion. Despite ...

Media members are seen during the New Year ceremony marking the opening of trading in 2025 at the Tokyo Stock Exchange (TSE) in Tokyo, Japan January 6, 2025. REUTERS/Issei Kato/File photo A look ...